Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects

AIDS Research and Human Retroviruses

Volumn 15, Issue 15, 1999, Pages 1365-1376

  Raux, M ^a   Finkielsztejn, L ^b   Salmon Ceron D ^b   Bouchez, H ^b   Excler, J L ^c   Dulioust, E ^b   Grouin, J M ^d   Sicard, D ^b   Blondeau, C ^a  

^a Clinical Sero Immunology Laboratory Pasteur Mérieux Connaught Parc Industriel d'Incarville   (France)

^b Université Paris Descartes   (France)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d UNIVERSITÉ DE ROUEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; SERUM ALBUMIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VAGINA SECRETION;

EID: 0033544014     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310070     Document Type: Article

References (47)

1. Girard M, Barré-Sinoussi F, Van der Ryst E, and Fultz P: An approach to vaccines against human immunodeficiency virus. AIDS Res Hum Retroviruses 1996;12:461-463.
2. Ada G and McElrath J: HIV type 1 vaccine-induced cytotoxic T cell responses: Potential role in vaccine efficacy. AIDS Res Hum Retroviruses 1997;3:205-210.
3. Mann JM: AIDS - the second decade: A global perspective. J Infect Dis 1992;165:245-250.
4. Mostad SB and Kreiss JK: Shedding of HIV1 in the genital tract. AIDS 1996;10:1305-1315.
5. Forrest D: Women, HIV, and mucosal immunity. Lancet 1991; 337:835-836.
6. McGhee JR, Mestecky J, Derzbaugh MT, Eldridge JH, Hirasawa M, and Kiyono H: The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 1992;10:75-88.
7. Mestecky J and Jackson S: Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines. J Clin Immunol 1994; 14:259-272.
8. Kiyono H, Miller C, Lu Y, Lehner T, Cranage M, Huang Y, Kawabata S, Marthas M, Roberts B, Nedrud J, Lamm M, Bergmeier L, Brookes R, Tao L, and McGhee J: The common mucosal immune system for the reproductive tract: basic principles applied towards AIDS vaccine. Adv Drug Deliv Rev 1995;18:23-51.
9. Milman G and Sharma O: Mechanisms of HIV/SIV mucosal transmission. AIDS Res Hum Retroviruses 1994;10:1305-1312.
10. Stefanache-Guichard AI: HIV vaccine and genital secretory immune response. Rom J Virol 1995;46:(1-2):85-98.
11. Essex M: Retroviral vaccines: Challenge for the developing world. AIDS Res Hum Retroviruses 1996;12:361-363.
12. Underdown BJ and Schiff JM: Immunoglobulin A: Strategic defence initiative at the mucosal surface. Annu Rev Immunol 1986;4:389-417.
13. Iscaki S and Bouvet JM: Human secretory immunoglobulin A and its role in mucosal defence. Bull Inst Pasteur 1993;91:203-224.
14. Mazanec MB, Nedrud JG, Kaetzel CS, and Lamm ME: A three-tiered view of the role of IgA in mucosal defence. Immunol Today 1993;14:430-435.
15. Archibald DW, Barr CE, Torosian JP, McLane F, and Essex M: Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS related complex. J Infect Dis 1987;155:793-796.
16. Kozlowski PA and Jackson S: Serum IgA subclasses and molecular forms in HIV infection: Selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies directed at Env glycoproteins. AIDS Res Hum Retroviruses 1992;10:1773-1780.
17. Matsuda S, Oka S, Honda M, Takebe Y, and Takemori T: Characteristics of IgA antibodies against HIV-1 in sera and saliva from HIV-seropositive individuals in different clinical stages. Scand J Immunol 1993;38:428-434.
18. Sweet SP, Rahman D, and Challacombe J: Serum and saliva immunoglobulin A concentrations show an inverse relationship in HIV infection and AIDS. AIDS 1995;9:1288-1289.
19. Sweet S. Rahman D, and Challacombe J: IgA subclasses in HIV disease; dichotomy between raised levels in serum and decreased secretion rates in saliva. Immunology 1995;86:556-559.
20. Behets FM, Edidi B, Quinn TC, Atikala L, Bishagaral K, Nzila N, Laga M, Piot P, Ryder RW, and Brown CC: Detection of salivary HIV-1 specific IgG antibodies in high risk populations in Zaïre. J AIDS 1991;4:183-187.
21. Wolff H, Mayer K, Seage G, Politch J, Horsburgh CH, and Anderson D: A comparison of HIV-1 antibody classes, titers, and specificities in paired semen and blood samples from HIV-1 seropositive men. J AIDS 1992;5:65-69.
22. Lü XS, Bélec L, and Pillot J: Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG cervicovaginal secretions from human immunodeficiency virus type1-infected women. J Infect Dis 1993;167:1189-1192.
23. Connel JA, Parry JV, Mortimer PP, and Duncam J: Novel assay for the detection of immunoglobulin G anti-human immunodeficiency virus in untreated saliva and urine. J Med Virol 1993;41: 159-164.
24. Lü XS, Delfraissy JF, Grangeot-Keros L, Rannon MT, and Pillot J: Rapid and constant detection of HIV antibody response in saliva of HIV infected patients: selective distribution of anti-HIV activity in the IgG isotype. Res Virol 1994;145:369-377.
25. Mohamed OA, Ashley R, Goldstein A, McElrath J, Dalessio J, and Corey L: Detection of rectal antibodies to HIV-1 by a sensitive chemoluminescent Western blot immunodetection method. J AIDS 1994;7:375-380.
26. Bélec L, Dupré T, Prazuck T, Tévi-Benissan C, Kanga JM, Pathey O, Lu XS, and Pillot J: Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995;172:691-697.
27. Artenstein AW, VanCott TC, Sitz KV, Robb L, Wagner KF, Veit S, Garner R, Byron J, Burnett P, and Birx D: Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: A comparison by site and correlation with clinical information. J Infect Dis 1997;175:265-271.
28. Haimovici F, Mayer KH, and Anderson DJ: Quantitation of HIV-1 specific IgG, IgA and IgM antibodies in human genital tract secretions. J AIDS Hum Retroviruses 1997;15:185-191.
29. Schneider T, Zippel T, Schmidt W, Pauli G, Heise W, Wahnschaffe U, Riecken E-O, Zeitz M, and Ullrich R: Abnormal predominance of IgG in HIV-specific antibodies produced by short-term cultured duodenal biopsy specimens from HIV-infected patients. J AIDS Hum Retroviruses 1997;16:333-339.
30. Raux M, Finkielsztejn L, Salmon-Céron D, Bouchez H, Excler JL, Dulioust E, Grouin JM, Sicard D, and Blondeau C: Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients. J Immunol Methods 1999;222:111-124.
31. Schaefer ME, Rhodes M, Prince S, Michalek SM, and McGree JR: A plastic intraoral device for the collection of human parotid saliva. J Dent Res 1977;56:728-733.
32. Lü X, Grangeot-Keros L, Blot A, Rannon MT, Delfraissy JF, and Pillot J: Comparison of saliva and serum for HIV antibody testing. In: IXth International Conference on AIDS 1993; Berlin, June 7-11. Abstract PO-B40-2457.
33. Bélec L, Meillet D, Levy M, Georges AJ, Tévi-Benissan C, and Pillot J: Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin Diag Lab Immunol 1995;2:57-61.
34. Nakane PK and Kawaoi A: Peroxidase labelled antibody, a new method of conjugation. J Histochem Cytochem 1974;22:1084-1091.
35. Jonard PP, Rambaud JC, Dive C, Vaerman JP, Gallan A, and Delacroix DL: Secretions of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest 1984;74:525-535.
36. Bélec L, Tévi-Benissan C, Lu XS, Prazuck T, and Pillot J: Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection. AIDS Res Hum Retroviruses 1995;11:719-729.
37. Pudney J and Anderson DJ: Immunobiology of the human penile urethrea. Am J Pathol 1995;147:155-165.
38. Janoff E, Jackson S, Wahl S, Thomas K, Peterman J, and Smith P: Intestinal mucosal immunoglobulins during human immunodeficiency virus type 1 infection. J Infect Dis 1994;170:299-307.
39. Holmström P, Syrjänen S, Laine P, Valle S-L, and Suni J: HIV antibodies in whole saliva detected by ELISA and Western blots assays. J Med Virol 1990;30:245-248.
40. Major CJ, Read SE, Coates RA, McLaughlin BJ, Millson M, Shepherd F, Fanning M, Calzavara L, MacFadden D, Johnson JK, and O'Shaughnessy MV: Comparison of saliva and blood for human immunodeficiency virus prevalence testing. J Infect Dis 1991;163: 699-702.
41. Van den Akker R, Van den Hoek A, Van den Akker W, Kooy H, Vijge E, Roosendall G, Coutinho R, and Van Loon A: Detection of antibodies in saliva as a tool for epidemiological studies. AIDS 1992;6:953-957.
42. Chamnanput J and Phanuphak P: Comparison of eight commercial kits for detecting anti-HIV antibodies in saliva specimens. AIDS 1993;7:1026.
43. Kutteh W and Mestecky J: Secretory immunity in the female reproductive tract. Am J Reprod Immun 1994;31:40-46.
44. O'Shea S, Cordery M, Barrett WY, Richman DD, Bradbeer C, and Batnavala JE: HIV excretion patterns and specific antibody responses in body fluids. J Med Virol 1990;31:291-296.
45. Cartry O, Moja P, Quesnel A, Pozzetto B, Lucht FR, and Genin C: Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection. Clin Exp Immunol 1997;109:47-53.
46. Jackson S, Dawson L, and Kotler D: IgA is the major immunoglobulin component of immune complexes in the acquired immune deficiency syndrome. J Clin Immunol 1988;8:64-68.
47. Müller F, Froland SS, Hvatum M, Radl J, and Brandtzaeg P: Both IgA subclasses are reduced in parotid saliva from patients with AIDS. Clin Exp Immunol 1991;83:203-209.